SPARC partners with UCSF and Tiller Therapeutics to license oncology asset
Agreement grants SPARC equity in Tiller for development and commercialisation of joint oncology intellectual property
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.